This company has been marked as potentially delisted and may not be actively trading. NYSE:IMPR Imprivata (IMPR) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About Imprivata Stock (NYSE:IMPR) 30 days 90 days 365 days Advanced Chart Get Imprivata alerts:Sign Up Key Stats Today's Range$19.26▼$19.2650-Day Range N/A52-Week Range$9.00▼$20.32VolumeN/AAverage Volume258,396 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewImprivata, Inc. (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure. Imprivata OneSign provides single sign-on, authentication management and virtual desktop roaming, enabling No Click Access to clinical applications and patient information, anytime, anywhere and from any device. Imprivata Cortext enables clinicians to collaborate across care teams and organizations. Imprivata Confirm ID is an identity and two-factor authentication platform for remote access, electronic prescriptions for controlled substances (EPCS), medical device access and other clinical authentication workflows. Imprivata PatientSecure is a patient identification solution that uses palm vein recognition biometrics to identify patients at any point of entry to care.Read More… Receive IMPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imprivata and its competitors with MarketBeat's FREE daily newsletter. Email Address IMPR Stock News HeadlinesDHA strengthens patient data security with NABIDH initiativeApril 27, 2025 | msn.comImprivata Introduces New Advanced Analytics Solution to Deliver Key Security and Operational Insights into Enterprise Mobile Device UsageApril 9, 2025 | finance.yahoo.comTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…May 6, 2025 | Crypto 101 Media (Ad)Over Half of UK Organisations Experienced a Security Breach Resulting from Third-Party Access in the Past Year, Imprivata Study FindsMarch 11, 2025 | finance.yahoo.comImprivata Study Finds Nearly Half of Organizations Suffered a Third-Party Security Incident in Past YearFebruary 13, 2025 | markets.businessinsider.comImprivata Enterprise Access Management Wins 2025 Best in KLAS Award for Access ManagementFebruary 5, 2025 | finance.yahoo.comTax incentives announced for life science companies in Mass.October 15, 2024 | msn.comHealthcare’s Password Problem And How To Fix ItOctober 8, 2024 | forbes.comSee More Headlines IMPR Stock Analysis - Frequently Asked Questions How were Imprivata's earnings last quarter? Imprivata, Inc. (NYSE:IMPR) posted its earnings results on Tuesday, February, 16th. The technology company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.10) by $0.01. The firm's revenue for the quarter was up 17.9% compared to the same quarter last year. What other stocks do shareholders of Imprivata own? Based on aggregate information from My MarketBeat watchlists, some other companies that Imprivata investors own include BioCryst Pharmaceuticals (BCRX), Teledyne FLIR (FLIR), Allegion (ALLE), Anixter International (AXE), Avigilon (AVO), Ascent Capital Group Inc Series A (ASCMA) and ASSA ABLOY AB (publ) (ASAZY). Company Calendar Last Earnings2/16/2016Today5/06/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:IMPR CIK1328015 Webwww.imprivata.com Phone+1-781-6742700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NYSE:IMPR) was last updated on 5/6/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredREVEALED: Elon’s Secret Master Plan “AGENDA X”REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...Brownstone Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump's $500B plan is fueling these monthly dividendsSomething extraordinary happened just 24 hours after Trump returned to office... He signed a document that ...Investors Alley | SponsoredConfidential Economic AdvisoryI've hesitated for months to record this video. The very act of sharing these details makes me deeply uncom...InvestorPlace | SponsoredThe New ElonThe New Face of DOGE? There is now a new, powerful and controversial figure at the heart of the DOGE agenda...Altimetry | SponsoredOur #1 Defense Stock for MayWe've already lost 18 straight simulated war games against China. The good news is, the U.S. military has a...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imprivata, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imprivata With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.